Synbio Tech Inc. (TPEX:1295)
50.00
-0.90 (-1.77%)
May 29, 2026, 1:30 PM CST
Synbio Tech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 149.95 | 175.97 | 170.13 | 113.27 | 92.52 |
Depreciation & Amortization | 93.21 | 75.85 | 72.48 | 76.88 | 77.27 |
Other Amortization | 3.38 | 3.38 | 3.57 | - | - |
Loss (Gain) From Sale of Assets | 1 | 0.83 | - | 0.06 | - |
Stock-Based Compensation | - | 3.48 | - | - | - |
Provision & Write-off of Bad Debts | -0.01 | 0.14 | - | - | 0.33 |
Other Operating Activities | -17.75 | -16.61 | 12.83 | 19.3 | 1.02 |
Change in Accounts Receivable | 10 | -4.77 | -5.01 | -27.04 | 25.21 |
Change in Inventory | -67.84 | -73.61 | -13.97 | 7.11 | 0.59 |
Change in Accounts Payable | -16.51 | -9.83 | 5.77 | 7.99 | -9.93 |
Change in Unearned Revenue | -4.89 | -4.66 | -5.8 | 8.52 | -0.21 |
Change in Other Net Operating Assets | -6.73 | -6.82 | 21.55 | 7.85 | 0.29 |
Operating Cash Flow | 143.83 | 143.35 | 261.54 | 213.93 | 187.09 |
Operating Cash Flow Growth | -32.25% | -45.19% | 22.25% | 14.35% | - |
Capital Expenditures | -666.04 | -703.07 | -302.15 | -327.29 | -216.63 |
Sale of Property, Plant & Equipment | 0.13 | 0.09 | - | 0.02 | - |
Sale (Purchase) of Intangibles | -1.75 | -1.95 | -8.8 | -0.41 | -3.64 |
Investment in Securities | -206.33 | -134.57 | -1.81 | 190.17 | 16.87 |
Other Investing Activities | 0.45 | 0.63 | -0.45 | 0.35 | -0.03 |
Investing Cash Flow | -873.53 | -838.87 | -313.21 | -137.17 | -203.43 |
Short-Term Debt Issued | - | 630.01 | 240.63 | - | - |
Long-Term Debt Issued | - | - | - | 301.02 | 267.22 |
Total Debt Issued | 872.19 | 630.01 | 240.63 | 301.02 | 267.22 |
Short-Term Debt Repaid | - | - | - | -72.5 | -107.72 |
Long-Term Debt Repaid | - | -207.45 | -28.49 | -117.87 | -29.55 |
Total Debt Repaid | -235.71 | -207.45 | -28.49 | -190.37 | -137.27 |
Net Debt Issued (Repaid) | 636.48 | 422.56 | 212.14 | 110.64 | 129.95 |
Issuance of Common Stock | 179.23 | 179.23 | - | - | - |
Common Dividends Paid | -109.74 | -109.74 | -46.11 | -61.48 | -70.15 |
Other Financing Activities | 0.15 | 0.15 | - | - | - |
Financing Cash Flow | 706.11 | 492.2 | 166.03 | 49.16 | 59.8 |
Foreign Exchange Rate Adjustments | 2.93 | 3.87 | 8.29 | -5.47 | -1.78 |
Net Cash Flow | -20.67 | -199.45 | 122.65 | 120.46 | 41.68 |
Free Cash Flow | -522.21 | -559.72 | -40.62 | -113.36 | -29.54 |
Free Cash Flow Margin | -51.22% | -53.89% | -4.11% | -13.77% | -4.00% |
Free Cash Flow Per Share | -15.15 | -16.79 | -1.29 | -3.60 | -0.94 |
Cash Interest Paid | 14.99 | 12.56 | 8.27 | 7.3 | 4.83 |
Cash Income Tax Paid | 40.06 | 40.13 | 42.75 | 18.41 | 27.27 |
Levered Free Cash Flow | -850.47 | -656.24 | -52.51 | 37.91 | - |
Unlevered Free Cash Flow | -837.5 | -648.32 | -50.19 | 42.04 | - |
Change in Working Capital | -85.95 | -99.69 | 2.54 | 4.43 | 15.95 |